Inventor
Dominique P. Bridon
Inventor
Outremont, CA
Overview
Patents· 39 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides29%
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C12NMicroorganisms or enzymes16%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
B01DSeparation1%
C07DHeterocyclic compounds1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
10,501,497Cyclic polypeptides, method for obtaining them and the therapeutic use thereof20198,093,206'Methods involving long lasting synthetic exendin-4 peptide conjugates'20128,084,414'Methods involving long lasting synthetic exendin-4-peptide conjugates'20118,080,516'Long lasting synthetic exendin-4 peptide conjugates'20118,039,432'Method of treatment of diabetes and/or obesity with reduced nausea side effect'20117,906,482'Anti-obesity agents'20117,741,286'Long lasting anti-angiogenic peptides'20107,741,453'Long lasting fusion peptide inhibitors for HIV infection'20107,737,251'Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders'20107,608,271'Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group'20097,601,691'Anti-obesity agents'20097,582,301'Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides'20097,307,148'Method for purification of albumin conjugates'20077,268,113'Long lasting growth hormone releasing factor derivatives'20077,256,253'Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components'20077,166,695'Affinity markers for human serum albumin'20077,144,854'Long lasting anti-angiogenic peptides'20067,112,567'Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders'20067,090,851'Long lasting fusion peptide inhibitors of viral infection'20066,887,849'Long lasting synthetic glucagon-like peptide {GLP-1}'20056,887,470'Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components'20056,849,714'Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components'20056,821,949'Long lasting synthetic glucagon-like peptide (GLP-1)'20046,706,892'Pulmonary delivery for bioconjugation'20046,610,825'Method for alleviating pain or providing an analgesic effect in a patient'20036,602,981'Antinociceptive agent derivative'20036,593,295'Long lasting insulinotropic peptides'20036,514,500'Long lasting synthetic glucagon like peptide GLP- '20036,500,918'Conjugate comprising an antinociceptive agent covalently bonded to a blood component'20026,440,417'Antibodies to argatroban derivatives and their use in therapeutic and diagnostic treatments'20026,437,092'Conjugates of opioids and endogenous carriers'20026,329,336'Long lasting insulinotropic peptides'20016,143,509'Prostate specific antigen peptides and uses thereof'20006,087,375'Methods of treating or preventing thromboses'20005,843,450'Hepatitis GB Virus synthetic peptides and uses thereof'19985,843,634'Genetically engineered enzymes and their conjugates for diagnostic assays'19985,800,983'Peptides for HIV-1 detection'19985,624,797'Peptides for HIV-1 detection'19975,516,647'Compounds useful as alkaline phosphatase inhibitors and therapeutic agents'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2000Patents assigned to ABBOTT LAB (5)· patent assignee history
1996–1998Based in Morton Grove, IL, US· patent location history
2000–2006Patents assigned to CONJUCHEM INC (17)· patent assignee history
2000–2009Based in Outremont, CA· patent location history
2000–2019Based in San Francisco, CA, US· patent location history
2006–2009Based in Mont-Royal, CA· patent location history
2007–2010Patents assigned to CONJUCHEM BIOTECHNOLOGIES INC (10)· patent assignee history
2010Based in Quebec, CA· patent location history
2011–2012Patents assigned to CONJUCHEM LLC (4)· patent assignee history
2011–2012Patents assigned to BRIDON DOMINIQUE P (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CONJUCHEM INC | 17 | 2000–2006 |
| CONJUCHEM BIOTECHNOLOGIES INC | 10 | 2007–2010 |
| ABBOTT LAB | 5 | 1996–2000 |
| CONJUCHEM LLC | 4 | 2011–2012 |
| BRIDON DOMINIQUE Pself | 3 | 2011–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Outremont, CA | 17 | 2000–2009 |
| San Francisco, California, US | 12 | 2000–2019 |
| Morton Grove, Illinois, US | 5 | 1996–1998 |
| Mont-Royal, CA | 4 | 2006–2009 |
| Quebec, CA | 1 | 2010 |